MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Orthostatic hypotension(OH)"

  • 2024 International Congress

    Orthostatic Hypotension is Associated with Worse Verbal Letter Fluency and Lower Neural Efficiency While Upright in Parkinson’s Disease: A Pilot Study

    K. Longardner, P. Reddy, K. Izzetoglu, I. Litvan (SAN DIEGO, USA)

    Objective: To evaluate positional effects on cognitive performance and cerebral hemodynamics in Parkinson’s disease (PD) patients with and without orthostatic hypotension (OH). Background: OH is…
  • 2024 International Congress

    Effect of Orthostatic Hypotension Medications on Orthostatic Ratio: A Systemic Review and Meta-Analysis

    V. Pham, M. Rashid, B. Kung, S. Hossain (Toledo, USA)

    Objective: To review potential effect of common orthostatic hypotension medications on orthostatic ratio Background: Orthostatic ratio, defined as change in heartrate over change in systolic…
  • 2024 International Congress

    Orthostatic Hypotension:a Clinical Marker for the Body-First Subtype of Patients with Parkinson’s Disease

    S. Mei, X. Wang, C. Han, P. Chan (Beijing, China)

    Objective: Our study aimed to investigate the clinical characteristics of PD patients stratified by OH status before and after levodopa challenge to explore the hypothesis…
  • 2024 International Congress

    Prevalence of Autonomic Symptoms in Mexican Population with Parkinson’s Disease

    A. Domínguez-García, A. Cervantes-Arriaga, M. Rodríguez-Violante, AJ. Hernández-Medrano, G. Rivera-Monroy, K. Velázquez-Román, AL. Guerra-Anzaldo, DP. Romero-Terán, WF. Moguel-Cardín, RJ. Baños-Betancourt, CF. álvarez-Hernández, D. Rebolledo-García (CDMX, Mexico)

    Objective: To Describe the prevalence of autonomic symptoms present in Mexican patients with Parkinson's Disease.To Describe the prevalence of autonomic symptoms present in Mexican patients…
  • 2024 International Congress

    Transcranial Magnetic Stimulation of Median Prefrontal Cortex Improves Orthostatic Hypotension in Parkinson’s Disease

    S. Antipenko, A. Frohlich, M. Sklerov (Chapel Hill, USA)

    Objective: To evaluate transcranial magnetic stimulation (TMS) as a potential therapeutic tool for treatment of orthostatic hypotension (OH) in Parkinson’s disease (PD). Background: Autonomic dysfunction,…
  • 2024 International Congress

    Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

    R. Freeman, I. Biaggioni, R. Vickery, L. Norcliffe-Kaufmann, T. Guerin, M. Bryarly, V. Iodice, M. Rudzniska-Bar, M. Boczarska-Jedynak, C. Oehlwein, C. Shibao, H. Kaufmann (Boston, USA)

    Objective: To assess the long-term safety and tolerability of ampreloxetine in patients with synucleinopathies (MSA, PD, and PAF) and symptomatic neurogenic orthostatic hypotension (nOH) from…
  • 2024 International Congress

    Nocturnal Hypertension in Parkinson’s Disease. The Flip Side of a Tainted Coin

    D. Wilson, M. Hagens, S. Nagaratnam, V. Fung (Sydney, Australia)

    Objective: To describe prevalence and severity of nocturnal hypertension and dipping in a cohort of patients with Parkinson’s disease undergoing 24hr blood pressure (BP) monitoring.…
  • 2023 International Congress

    Impact of orthostatic hypotension with sleep disturbance on cognition

    A. Ovchynnykova, E. Trufanov (Kyiv, Ukraine)

    Objective: To define features of cognitive decline in a group of patients with orthostatic hypotension combined with sleep disorders. Background: recent data suggest that orthostatic…
  • 2023 International Congress

    An Analysis of Subgroups of Multiple System Atrophy Patients from Ampreloxetine Phase 3 Trials

    R. Freeman, I. Biaggioni, L. Norcliffe-Kaufmann, T. Guerin, R. Vickery, L. Manzanares, V. Iodice, M. Rudzińska-Bar, M. Pellecchia, H. Kaufmann (Boston, USA)

    Objective: To present results in the subset of patients with multiple system atrophy (MSA) and relevant MSA subgroups from two ampreloxetine phase 3 trials for…
  • 2023 International Congress

    Machine Learning Model for Prediction of acute orthostatic hypotension after levodopa administration

    Z. Liu, SN. Lin, ZL. Chen, Y. Ling, T. Feng (Beijing, China)

    Objective: The aim of this study is to develop and validate a prediction model of AOHPL to facilitate physicians in identifying patients at higher probability…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley